<?xml version="1.0" encoding="UTF-8"?>
<p id="p0170">As of now, five patients with ADEM have been reported after CoV infection; one adolescent with HCoV-OC43 [
 <xref rid="bb0085" ref-type="bibr">17</xref>] and 4 adults after SARS-CoV-2. [
 <xref rid="bb0600" ref-type="bibr">[120]</xref>, 
 <xref rid="bb0605" ref-type="bibr">[121]</xref>, 
 <xref rid="bb0610" ref-type="bibr">[122]</xref>, 
 <xref rid="bb0615" ref-type="bibr">[123]</xref>] relation between CoV infections and demyelinating diseases of CNS has been suggested in last decades. [
 <xref rid="bb0060" ref-type="bibr">12</xref>,
 <xref rid="bb0620" ref-type="bibr">124</xref>] Despite the fact of ADEM usually occurring in children [
 <xref rid="bb0085" ref-type="bibr">17</xref>], in the current pandemic all reported ADEM patients were older than 50-year-old. This finding might be due to higher prevalence of COVID-19 in adults. From the reported patients, two recovered with methylprednisolone and intravenous immunoglobulins [
 <xref rid="bb0600" ref-type="bibr">120</xref>,
 <xref rid="bb0605" ref-type="bibr">121</xref>] and two of them died [
 <xref rid="bb0610" ref-type="bibr">122</xref>,
 <xref rid="bb0615" ref-type="bibr">123</xref>], one was a 71-year-old-man with underlying comorbidities and ADEM was diagnosed in post-mortem biopsy. [
 <xref rid="bb0610" ref-type="bibr">122</xref>] The other one was a 58-year-old man who was treated with dexamethasone and died as consequence of status epilepticus. [
 <xref rid="bb0615" ref-type="bibr">123</xref>] (
 <xref rid="f0025" ref-type="fig">Figure. 5</xref> )
</p>
